MovDisordV3, Main, Curation, bibRecord, 004836

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

Identifieur interne : 004836 ( Main/Curation ); précédent : 004835; suivant : 004837

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

Auteurs : Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]

Source :

Movement Disorders [ 0885-3185 ] ; 2001-03.

RBID : ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E

Descripteurs français

Pascal (Inist)
- Agoniste, Antiparkinsonien, Apomorphine, Chimiothérapie, Conférence consensus, Diagnostic, Epreuve pharmacologique, Homme, Lévodopa, Parkinson maladie, Recommandation, Récepteur dopaminergique, Stimulant dopaminergique, Traitement.
Wicri :
- topic : Homme, Recommandation.

English descriptors

KwdEn :
- Agonist, Antiparkinson agent, Apomorphine (administration & dosage), Apomorphine (diagnostic use), Apomorphine (pharmacology), Chemotherapy, Consensus conference, Corpus Striatum (drug effects), Decision Making, Diagnosis, Domperidone (administration & dosage), Domperidone (diagnostic use), Domperidone (pharmacology), Dopamine Agonists (administration & dosage), Dopamine Agonists (diagnostic use), Dopamine Agonists (pharmacology), Dopamine Antagonists (administration & dosage), Dopamine Antagonists (diagnostic use), Dopamine Antagonists (pharmacology), Dopamine agonist, Dopamine receptor, Drug Administration Schedule, Guidelines as Topic, Human, Humans, Levodopa, Levodopa (administration & dosage), Levodopa (diagnostic use), Levodopa (pharmacology), Parkinson Disease (diagnosis), Parkinson disease, Pharmacologic test, Recommendation, Substantia Nigra (drug effects), Time Factors, Treatment, apomorphine, diagnosis, levodopa, treatment.
MESH :
- chemical , administration & dosage : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- chemical , diagnostic use : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- chemical , pharmacology : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- diagnosis : Parkinson Disease.
- drug effects : Corpus Striatum, Substantia Nigra.
- Decision Making, Drug Administration Schedule, Guidelines as Topic, Humans, Time Factors.

Abstract

Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders. © 2001 Movement Disorder Society.

Url:

https://api.istex.fr/document/3638D905253CBADE5F33953F6B488F265CEAEE7E/fulltext/pdf

DOI: 10.1002/mds.1069

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002A93
to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :002A93
to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003064
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006D19
to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002A25
to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000296
to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002A28
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006F27
to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003D91
to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003D91
to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003D80
to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000460
to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000460
to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000460
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006A82

Links to Exploration step

ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title>
<author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name>
</author>
<author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name>
</author>
<author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name>
</author>
<author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name>
</author>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
</author>
<author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name>
</author>
<author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation><country>France</country>
<placeName><settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<orgName type="hospital" n="4">Centre hospitalier universitaire Grenoble Alpes</orgName>
</affiliation>
</author>
<author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name>
</author>
<author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1002/mds.1069</idno>
<idno type="url">https://api.istex.fr/document/3638D905253CBADE5F33953F6B488F265CEAEE7E/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002A93</idno>
<idno type="wicri:Area/Istex/Curation">002A93</idno>
<idno type="wicri:Area/Istex/Checkpoint">003064</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno>
<idno type="wicri:Area/Main/Merge">006D19</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:01-0333009</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002A25</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000296</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002A28</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno>
<idno type="wicri:Area/Main/Merge">006F27</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11295770</idno>
<idno type="wicri:Area/PubMed/Corpus">003D91</idno>
<idno type="wicri:Area/PubMed/Curation">003D91</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003D80</idno>
<idno type="wicri:Area/Ncbi/Merge">000460</idno>
<idno type="wicri:Area/Ncbi/Curation">000460</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000460</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno>
<idno type="wicri:Area/Main/Merge">006A82</idno>
<idno type="wicri:Area/Main/Curation">004836</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title>
<author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico, Milano</wicri:regionArea>
<wicri:noRegion>Milano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinica Neurologica, Università di Pisa, Pisa</wicri:regionArea>
<wicri:noRegion>Pisa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455, Toulouse</wicri:regionArea>
<placeName><settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, King's College Hospital, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
<affiliation wicri:level="4"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
</affiliation>
</author>
<author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps‐Universität Marburg</wicri:regionArea>
<wicri:noRegion>Philipps‐Universität Marburg</wicri:noRegion>
<wicri:noRegion>Philipps‐Universität Marburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name>
<affiliation wicri:level="1"><country xml:lang="fr">Israël</country>
<wicri:regionArea>Department of Neurology, Beilinson Medical Centre, Sackler Medical School, Tel‐Aviv</wicri:regionArea>
<wicri:noRegion>Tel‐Aviv</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Université J. Fourier, Grenoble</wicri:regionArea>
<placeName><settlement type="city">Grenoble</settlement>
</placeName>
<placeName><settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<orgName type="hospital" n="4">Centre hospitalier universitaire Grenoble Alpes</orgName>
</affiliation>
</author>
<author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Centre, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinica Neurologica, Università di Catanzaro, Catanzaro</wicri:regionArea>
<wicri:noRegion>Catanzaro</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2001-03">2001-03</date>
<biblScope unit="vol">16</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="197">197</biblScope>
<biblScope unit="page" to="201">201</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">3638D905253CBADE5F33953F6B488F265CEAEE7E</idno>
<idno type="DOI">10.1002/mds.1069</idno>
<idno type="ArticleID">MDS1069</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Antiparkinson agent</term>
<term>Apomorphine (administration & dosage)</term>
<term>Apomorphine (diagnostic use)</term>
<term>Apomorphine (pharmacology)</term>
<term>Chemotherapy</term>
<term>Consensus conference</term>
<term>Corpus Striatum (drug effects)</term>
<term>Decision Making</term>
<term>Diagnosis</term>
<term>Domperidone (administration & dosage)</term>
<term>Domperidone (diagnostic use)</term>
<term>Domperidone (pharmacology)</term>
<term>Dopamine Agonists (administration & dosage)</term>
<term>Dopamine Agonists (diagnostic use)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Antagonists (administration & dosage)</term>
<term>Dopamine Antagonists (diagnostic use)</term>
<term>Dopamine Antagonists (pharmacology)</term>
<term>Dopamine agonist</term>
<term>Dopamine receptor</term>
<term>Drug Administration Schedule</term>
<term>Guidelines as Topic</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (diagnostic use)</term>
<term>Levodopa (pharmacology)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson disease</term>
<term>Pharmacologic test</term>
<term>Recommendation</term>
<term>Substantia Nigra (drug effects)</term>
<term>Time Factors</term>
<term>Treatment</term>
<term>apomorphine</term>
<term>diagnosis</term>
<term>levodopa</term>
<term>treatment</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Corpus Striatum</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Decision Making</term>
<term>Drug Administration Schedule</term>
<term>Guidelines as Topic</term>
<term>Humans</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Agoniste</term>
<term>Antiparkinsonien</term>
<term>Apomorphine</term>
<term>Chimiothérapie</term>
<term>Conférence consensus</term>
<term>Diagnostic</term>
<term>Epreuve pharmacologique</term>
<term>Homme</term>
<term>Lévodopa</term>
<term>Parkinson maladie</term>
<term>Recommandation</term>
<term>Récepteur dopaminergique</term>
<term>Stimulant dopaminergique</term>
<term>Traitement</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Recommandation</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders. © 2001 Movement Disorder Society.</div>
</front>
</TEI>
<double idat="0885-3185:2001:Albanese A:consensus:statement:on"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title>
<author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Milano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinica Neurologica, Università di Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Pisa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Department of Neurology, King's College Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
<affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Dipartimento di Scienze Neurologiche, Università La Sapienza</s1>
<s2>Roma</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
</affiliation>
</author>
<author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps-Universität Marburg</s1>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Philipps-Universität Marburg</wicri:noRegion>
<wicri:noRegion>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps-Universität Marburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Neurology, Beilinson Medical Centre, Sackler Medical School</s1>
<s2>Tel-Aviv</s2>
<s3>ISR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Tel-Aviv</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Service de Neurologie, Université J. Fourier</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Grenoble</settlement>
</placeName>
<placeName><settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<orgName type="hospital" n="4">Centre hospitalier universitaire Grenoble Alpes</orgName>
</affiliation>
</author>
<author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name>
<affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Department of Neurology, Leiden University Medical Centre</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Clinica Neurologica, Università di Catanzaro</s1>
<s2>Catanzaro</s2>
<s3>ITA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Catanzaro</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">01-0333009</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 01-0333009 INIST</idno>
<idno type="RBID">Pascal:01-0333009</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002A25</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000296</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002A28</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno>
<idno type="wicri:Area/Main/Merge">006F27</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title>
<author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Milano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinica Neurologica, Università di Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Pisa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Department of Neurology, King's College Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
<affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Dipartimento di Scienze Neurologiche, Università La Sapienza</s1>
<s2>Roma</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
</affiliation>
</author>
<author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps-Universität Marburg</s1>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Philipps-Universität Marburg</wicri:noRegion>
<wicri:noRegion>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps-Universität Marburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Neurology, Beilinson Medical Centre, Sackler Medical School</s1>
<s2>Tel-Aviv</s2>
<s3>ISR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Tel-Aviv</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Service de Neurologie, Université J. Fourier</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Grenoble</settlement>
</placeName>
<placeName><settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<orgName type="hospital" n="4">Centre hospitalier universitaire Grenoble Alpes</orgName>
</affiliation>
</author>
<author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name>
<affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Department of Neurology, Leiden University Medical Centre</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Clinica Neurologica, Università di Catanzaro</s1>
<s2>Catanzaro</s2>
<s3>ITA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Catanzaro</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Consensus conference</term>
<term>Diagnosis</term>
<term>Dopamine agonist</term>
<term>Dopamine receptor</term>
<term>Human</term>
<term>Levodopa</term>
<term>Parkinson disease</term>
<term>Pharmacologic test</term>
<term>Recommendation</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Epreuve pharmacologique</term>
<term>Lévodopa</term>
<term>Antiparkinsonien</term>
<term>Chimiothérapie</term>
<term>Apomorphine</term>
<term>Stimulant dopaminergique</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique</term>
<term>Conférence consensus</term>
<term>Recommandation</term>
<term>Diagnostic</term>
<term>Traitement</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Recommandation</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title>
<author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name>
</author>
<author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name>
</author>
<author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name>
</author>
<author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name>
</author>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
</author>
<author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name>
</author>
<author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation><country>France</country>
<placeName><settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<orgName type="hospital" n="4">Centre hospitalier universitaire Grenoble Alpes</orgName>
</affiliation>
</author>
<author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name>
</author>
<author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1002/mds.1069</idno>
<idno type="url">https://api.istex.fr/document/3638D905253CBADE5F33953F6B488F265CEAEE7E/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002A93</idno>
<idno type="wicri:Area/Istex/Curation">002A93</idno>
<idno type="wicri:Area/Istex/Checkpoint">003064</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno>
<idno type="wicri:Area/Main/Merge">006D19</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title>
<author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico, Milano</wicri:regionArea>
<wicri:noRegion>Milano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinica Neurologica, Università di Pisa, Pisa</wicri:regionArea>
<wicri:noRegion>Pisa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455, Toulouse</wicri:regionArea>
<placeName><settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, King's College Hospital, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
<affiliation wicri:level="4"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
</affiliation>
</author>
<author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps‐Universität Marburg</wicri:regionArea>
<wicri:noRegion>Philipps‐Universität Marburg</wicri:noRegion>
<wicri:noRegion>Philipps‐Universität Marburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name>
<affiliation wicri:level="1"><country xml:lang="fr">Israël</country>
<wicri:regionArea>Department of Neurology, Beilinson Medical Centre, Sackler Medical School, Tel‐Aviv</wicri:regionArea>
<wicri:noRegion>Tel‐Aviv</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Université J. Fourier, Grenoble</wicri:regionArea>
<placeName><settlement type="city">Grenoble</settlement>
</placeName>
<placeName><settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<orgName type="hospital" n="4">Centre hospitalier universitaire Grenoble Alpes</orgName>
</affiliation>
</author>
<author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Centre, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinica Neurologica, Università di Catanzaro, Catanzaro</wicri:regionArea>
<wicri:noRegion>Catanzaro</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2001-03">2001-03</date>
<biblScope unit="vol">16</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="197">197</biblScope>
<biblScope unit="page" to="201">201</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">3638D905253CBADE5F33953F6B488F265CEAEE7E</idno>
<idno type="DOI">10.1002/mds.1069</idno>
<idno type="ArticleID">MDS1069</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson disease</term>
<term>apomorphine</term>
<term>diagnosis</term>
<term>levodopa</term>
<term>treatment</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders. © 2001 Movement Disorder Society.</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.</title>
<author><name sortKey="Albanese, A" sort="Albanese, A" uniqKey="Albanese A" first="A" last="Albanese">A. Albanese</name>
<affiliation wicri:level="1"><nlm:affiliation>Istituto di Neurologia, Università Cattolica, Milano, Italy. alberto.albanese@rm.unicatt.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Neurologia, Università Cattolica, Milano</wicri:regionArea>
<wicri:noRegion>Milano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, U" sort="Bonuccelli, U" uniqKey="Bonuccelli U" first="U" last="Bonuccelli">U. Bonuccelli</name>
</author>
<author><name sortKey="Brefel, C" sort="Brefel, C" uniqKey="Brefel C" first="C" last="Brefel">C. Brefel</name>
</author>
<author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name>
</author>
<author><name sortKey="Colosimo, C" sort="Colosimo, C" uniqKey="Colosimo C" first="C" last="Colosimo">C. Colosimo</name>
</author>
<author><name sortKey="Eichhorn, T" sort="Eichhorn, T" uniqKey="Eichhorn T" first="T" last="Eichhorn">T. Eichhorn</name>
</author>
<author><name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
</author>
<author><name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P" last="Pollak">P. Pollak</name>
</author>
<author><name sortKey="Van Laar, T" sort="Van Laar, T" uniqKey="Van Laar T" first="T" last="Van Laar">T. Van Laar</name>
</author>
<author><name sortKey="Zappia, M" sort="Zappia, M" uniqKey="Zappia M" first="M" last="Zappia">M. Zappia</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11295770</idno>
<idno type="pmid">11295770</idno>
<idno type="wicri:Area/PubMed/Corpus">003D91</idno>
<idno type="wicri:Area/PubMed/Curation">003D91</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003D80</idno>
<idno type="wicri:Area/Ncbi/Merge">000460</idno>
<idno type="wicri:Area/Ncbi/Curation">000460</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000460</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno>
<idno type="wicri:Area/Main/Merge">006A82</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.</title>
<author><name sortKey="Albanese, A" sort="Albanese, A" uniqKey="Albanese A" first="A" last="Albanese">A. Albanese</name>
<affiliation wicri:level="1"><nlm:affiliation>Istituto di Neurologia, Università Cattolica, Milano, Italy. alberto.albanese@rm.unicatt.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Neurologia, Università Cattolica, Milano</wicri:regionArea>
<wicri:noRegion>Milano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, U" sort="Bonuccelli, U" uniqKey="Bonuccelli U" first="U" last="Bonuccelli">U. Bonuccelli</name>
</author>
<author><name sortKey="Brefel, C" sort="Brefel, C" uniqKey="Brefel C" first="C" last="Brefel">C. Brefel</name>
</author>
<author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name>
</author>
<author><name sortKey="Colosimo, C" sort="Colosimo, C" uniqKey="Colosimo C" first="C" last="Colosimo">C. Colosimo</name>
</author>
<author><name sortKey="Eichhorn, T" sort="Eichhorn, T" uniqKey="Eichhorn T" first="T" last="Eichhorn">T. Eichhorn</name>
</author>
<author><name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
</author>
<author><name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P" last="Pollak">P. Pollak</name>
</author>
<author><name sortKey="Van Laar, T" sort="Van Laar, T" uniqKey="Van Laar T" first="T" last="Van Laar">T. Van Laar</name>
</author>
<author><name sortKey="Zappia, M" sort="Zappia, M" uniqKey="Zappia M" first="M" last="Zappia">M. Zappia</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Apomorphine (administration & dosage)</term>
<term>Apomorphine (diagnostic use)</term>
<term>Apomorphine (pharmacology)</term>
<term>Corpus Striatum (drug effects)</term>
<term>Decision Making</term>
<term>Domperidone (administration & dosage)</term>
<term>Domperidone (diagnostic use)</term>
<term>Domperidone (pharmacology)</term>
<term>Dopamine Agonists (administration & dosage)</term>
<term>Dopamine Agonists (diagnostic use)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Antagonists (administration & dosage)</term>
<term>Dopamine Antagonists (diagnostic use)</term>
<term>Dopamine Antagonists (pharmacology)</term>
<term>Drug Administration Schedule</term>
<term>Guidelines as Topic</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (diagnostic use)</term>
<term>Levodopa (pharmacology)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Substantia Nigra (drug effects)</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Corpus Striatum</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Decision Making</term>
<term>Drug Administration Schedule</term>
<term>Guidelines as Topic</term>
<term>Humans</term>
<term>Time Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders.</div>
</front>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004836 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004836 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E
   |texte=   Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri